About us

Efferon was founded by a team of original polymeric adsorbents developers (Faculty of Chemistry, Lomonosov Moscow State University and Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences). We are European company with a core technology coming from Russian scientists.

An international patent for the production and application of adsorbents includes dozens of countries, including the United States, China, the European Union and Russia. Polymeric adsorbent beads with a huge internal volume (700-900 m2/g) and chemically modified surface are capable of selective adsorption of toxic substances, bacterial endotoxins and cytokines. The implemented and functioning quality management system of the enterprise is certified for compliance with the requirements of ISO 13485-2016 standards.

Two medical devices Efferon LPS and Efferon CT were approved for clinical use in Russia in 2019. These are sterile single-use devices for extracorporeal blood purification from toxic substances and inflammatory mediators. They are used in intensive care units in the treatment of life-threatening conditions: sepsis, multiple organ failure, and cytokine storm syndrome.

Company is working both on expanding the evidence base for already released products and on creating new ones.